Daniel Joseph O Connell Acumen Pharmaceuticals, Inc. (ABOS) insider trading activity

ABOS Quotes by TradingView

Daniel Joseph O Connell is Chief Executive Officer of Acumen Pharmaceuticals, Inc.. Currently has a direct ownership of 680,107 shares of ABOS, which is worth approximately $1.12 Million. The most recent transaction as insider was on Jan 07, 2025, when has been sold 225,400 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 680K
35.35% 3M change
31.37% 12M change
Total Value Held $1.12 Million

Daniel Joseph OConnell Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 07 2025
BUY
Grant, award, or other acquisition
-
225,400 Added 24.89%
680,107 Common Stock
Jan 03 2025
SELL
Open market or private sale
$87,911 $1.84 p/Share
47,778 Reduced 9.51%
454,707 Common Stock
Jan 19 2024
SELL
Open market or private sale
$52,744 $3.47 p/Share
15,200 Reduced 2.94%
502,485 Common Stock
Jan 02 2024
BUY
Grant, award, or other acquisition
-
401,000 Added 43.65%
517,685 Common Stock
Jan 17 2023
BUY
Grant, award, or other acquisition
-
114,000 Added 49.42%
116,685 Common Stock
Nov 30 2021
BUY
Exercise of conversion of derivative security
$4,997 $4.47 p/Share
1,118 Added 29.4%
2,685 Common Stock
Jul 06 2021
SELL
Payment of exercise price or tax liability
$160 $16.0 p/Share
10 Reduced 0.63%
1,567 Common Stock
Jul 06 2021
BUY
Exercise of in-the-money or at-the-money derivatives securities
$156 $4.47 p/Share
35 Added 2.17%
1,577 Common Stock
Jul 06 2021
BUY
Conversion of derivative security
-
123 Added 7.39%
1,542 Common Stock
DJO

Daniel Joseph O Connell

Chief Executive Officer
Charlottesville, VA

Track Institutional and Insider Activities on ABOS

Follow Acumen Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABOS shares.

Notify only if

Insider Trading

Get notified when an Acumen Pharmaceuticals, Inc. insider buys or sells ABOS shares.

Notify only if

News

Receive news related to Acumen Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ABOS